Cargando…
Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299629/ https://www.ncbi.nlm.nih.gov/pubmed/28210661 http://dx.doi.org/10.1212/NXI.0000000000000325 |
| _version_ | 1782506061347946496 |
|---|---|
| author | Hodecker, Sibylle C. Stürner, Klarissa H. Becker, Veit Elias-Hamp, Birte Holst, Brigitte Friese, Manuel A. Heesen, Christoph |
| author_facet | Hodecker, Sibylle C. Stürner, Klarissa H. Becker, Veit Elias-Hamp, Birte Holst, Brigitte Friese, Manuel A. Heesen, Christoph |
| author_sort | Hodecker, Sibylle C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5299629 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-52996292017-02-16 Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS Hodecker, Sibylle C. Stürner, Klarissa H. Becker, Veit Elias-Hamp, Birte Holst, Brigitte Friese, Manuel A. Heesen, Christoph Neurol Neuroimmunol Neuroinflamm Clinical/Scientific Notes Lippincott Williams & Wilkins 2017-02-08 /pmc/articles/PMC5299629/ /pubmed/28210661 http://dx.doi.org/10.1212/NXI.0000000000000325 Text en Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Clinical/Scientific Notes Hodecker, Sibylle C. Stürner, Klarissa H. Becker, Veit Elias-Hamp, Birte Holst, Brigitte Friese, Manuel A. Heesen, Christoph Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS |
| title | Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS |
| title_full | Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS |
| title_fullStr | Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS |
| title_full_unstemmed | Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS |
| title_short | Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS |
| title_sort | maraviroc as possible treatment for pml-iris in natalizumab-treated patients with ms |
| topic | Clinical/Scientific Notes |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299629/ https://www.ncbi.nlm.nih.gov/pubmed/28210661 http://dx.doi.org/10.1212/NXI.0000000000000325 |
| work_keys_str_mv | AT hodeckersibyllec maravirocaspossibletreatmentforpmlirisinnatalizumabtreatedpatientswithms AT sturnerklarissah maravirocaspossibletreatmentforpmlirisinnatalizumabtreatedpatientswithms AT beckerveit maravirocaspossibletreatmentforpmlirisinnatalizumabtreatedpatientswithms AT eliashampbirte maravirocaspossibletreatmentforpmlirisinnatalizumabtreatedpatientswithms AT holstbrigitte maravirocaspossibletreatmentforpmlirisinnatalizumabtreatedpatientswithms AT friesemanuela maravirocaspossibletreatmentforpmlirisinnatalizumabtreatedpatientswithms AT heesenchristoph maravirocaspossibletreatmentforpmlirisinnatalizumabtreatedpatientswithms |